Susan Windham-Bannister

Insider Reports History

Entity
Individual
Location
78 Blanchard Road, Burlington, MA
Signature
/s/ Susan Windham-Bannister
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Windham-Bannister:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aridis Pharmaceuticals, Inc. Director Stock options 261K Jun 27, 2024 Direct
Humacyte, Inc. Director Stock Options (right to buy) 50K Jun 13, 2024 Direct
Histogen Inc. Director Stock Option (right to buy) 6.84K Jun 20, 2023 Direct

Insider Reports Filed by Susan Windham-Bannister

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARDS Aridis Pharmaceuticals, Inc. Jun 27, 2024 1 $0 4 Jun 28, 2024 Director
HUMA Humacyte, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
ARDS Aridis Pharmaceuticals, Inc. Sep 18, 2023 1 $0 4 Sep 19, 2023 Director
HSTO Histogen Inc. Jun 20, 2023 1 $0 4 Jun 21, 2023 Director
HUMA Humacyte, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
ARDS Aridis Pharmaceuticals, Inc. May 4, 2023 3 $0 4 Jun 15, 2023 Director
ARDS Aridis Pharmaceuticals, Inc. Dec 5, 2022 1 $0 4 Dec 7, 2022 Director
HUMA Humacyte, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
HSTO Histogen Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
HUMA Humacyte, Inc. Oct 13, 2021 1 $0 4 Oct 15, 2021 Director
ARDS Aridis Pharmaceuticals, Inc. Oct 4, 2021 1 $0 4 Oct 5, 2021 Director
HUMA Humacyte, Inc. Aug 26, 2021 0 $0 3 Aug 27, 2021 Director